FELIX
CARBONELL RAMON

EMÉRITO/A UNIVERSIDAD

Foto de FELIX

Foto de Hospital Ramón y Cajal

Hospital Ramón y Cajal

Madrid, España

Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (6)

2019

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance
Haematologica, Vol. 104, Núm. 11, pp. 2249-2257

2014

Simplification of risk stratification for splenic marginal zone lymphoma: A point-based score for practical use
Leukemia and Lymphoma
Vascular Endothelial Growth Factor a ( VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia
PLoS ONE, Vol. 9, Núm. 6

2012

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases
British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171

1993

Interferon alpha 2a in the treatment of chronic myelogenous leukemia in chronic phase. Results of the Spanish group
Leukemia and Lymphoma, Vol. 11, Núm. s1, pp. 175-179

1986

Cytogenetic studies in 18 patients with secondary blood disorders
Cancer Genetics and Cytogenetics, Vol. 22, Núm. 4, pp. 309-317